Safety of Artemisinin Derivatives in the First Trimester of Pregnancy: A Controversial Story
Artemisinin combination therapy (ACT) is recommended by the World Health Organization (WHO) as first line treatment for uncomplicated malaria both in adults and children. During pregnancy, ACT is considered safe only in the second and third trimester, since animal studies have demonstrated that arte...
Main Authors: | Sarah D’Alessandro, Elena Menegola, Silvia Parapini, Donatella Taramelli, Nicoletta Basilico |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/15/3505 |
Similar Items
-
Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges
by: Makoto Saito, et al.
Published: (2017-12-01) -
Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the <i>Plasmodium</i> Life Cycle
by: Helenita C. Quadros, et al.
Published: (2021-11-01) -
Artemisinin-resistant malaria and a prevention strategy
by: Francis M Malwal
Published: (2020-12-01) -
From bark to weed: The history of artemisinin
by: Faurant C.
Published: (2011-08-01) -
The current use of the artemisinin-based Combination Therapies in adult patients at a Tertiary Hospital, South-South Nigeria
by: STEPHEN AYINBUOMWAN, et al.
Published: (2022-12-01)